tiprankstipranks
B.M.P. Pharma Trading AG (DE:BMP)
BERLIN:BMP
Germany Market
Holding DE:BMP?
Track your performance easily

B.M.P. Pharma Trading AG (BMP) Income Statement

2 Followers

B.M.P. Pharma Trading AG Income Statement

Last quarter (Q ), B.M.P. Pharma Trading AG's total revenue was €―, a decrease of ― from previous quarter. In Q, B.M.P. Pharma Trading AG's net income was €―. See B.M.P. Pharma Trading AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-€ 4.45K€ 1.00K€ 1.00K€ 7.00K€ 2.00K
Cost of Revenue
-€ 3.91K€ 1.00K€ 1.00K€ 3.00K€ 0.00
Gross Profit
-€ 546.28€ 0.00€ 0.00€ 4.00K€ 2.00K
Operating Expense
-€ 795.47K€ 693.00K€ 685.00K€ 687.00K€ 655.00K
Operating Income
-€ -794.92K€ -693.00K€ -685.00K€ -683.00K€ -653.00K
Net Non Operating Interest Income Expense
-€ -13.41K€ 3.00K€ 20.00K€ 17.00K€ 17.00K
Other Income Expense
------
Pretax Income
-€ 3.21M€ 298.00K€ 341.00K€ 545.00K€ 113.00K
Tax Provision
-€ 593.49K€ 128.00K€ 32.00K€ -85.00K€ -96.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ 2.62M€ 170.00K€ 309.00K€ 460.00K€ 17.00K
Basic EPS
-€ 0.50€ 0.03€ 0.06€ 0.09€ <0.01
Diluted EPS
-€ 0.50€ 0.03€ 0.06€ 0.09€ <0.01
Basic Average Shares
-€ 5.25M€ 5.25M€ 5.25M€ 5.25M€ 5.25M
Diluted Average Shares
-€ 5.25M€ 5.25M€ 5.25M€ 5.25M€ 5.25M
Dividend Per Share
-€ 0.02----
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-€ 799.38K€ 694.00K€ 686.00K€ 690.00K€ 655.00K
Net Income From Continuing And Discontinued Operation
-€ 2.62M€ 170.00K€ 309.00K€ 460.00K€ 17.00K
Normalized Income
-€ 2.62M€ 170.00K€ 309.00K€ 460.00K€ 17.00K
Interest Expense
-€ 13.43K€ 2.00K€ 0.00€ 0.00€ 1.00K
EBIT
-€ 3.23M€ 300.00K€ 341.00K€ 545.00K€ 114.00K
EBITDA
-€ 3.23M€ 300.00K€ 342.00K€ 546.00K€ 115.00K
Currency in EUR

B.M.P. Pharma Trading AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis